Overview of CRISPR
CRISPR is a groundbreaking technology that is reshaping lives and creating a stir in the healthcare sector. CRISPR, an abbreviation for “Clustered Regularly Interspaced Short Palindromic Repeats,” exists in prokaryotes—tiny, unicellular organisms devoid of organelles. These sequences are embedded within the genomes of prokaryotes, which arrange a cell’s DNA in clusters.
As a tool for gene editing, CRISPR allows for the alteration of targeted areas of DNA to combat severe illnesses. Its efficiency lies in its ability to help protect the organism from viral invasions by assimilating foreign DNA into its genome, equipping it to recognize and eliminate the virus in subsequent exposures. Notably, CRISPR stands out for its superior precision and user-friendly programming compared to alternative gene editing techniques, facilitating a more straightforward sequence alteration process. While other gene-editing approaches usually employ a single protein, CRISPR utilizes RNA-guided targeting along with the Cas9 enzyme.
The Mechanism of CRISPR
CRISPR operates by leveraging a natural defense mechanism present in bacteria that enables them to detect and obliterate viral threats. When a virus penetrates a bacterial cell (a prokaryote), the bacterium encodes a section of the virus’s DNA into its own genome, functioning as a genetic “memory.” This process allows the bacterium to identify and react more adeptly to future viral attacks.
For gene editing, this mechanism is fine-tuned using two essential components: the Cas9 enzyme, which acts like molecular scissors to sever DNA, and guide RNA, which instructs Cas9 to the exact genetic sequence requiring modification. After the targeted DNA is severed, the cell’s inherent repair systems engage, enabling researchers to implement alterations in the genetic structure.
In contrast to previous tools that depended on difficult-to-reprogram proteins, CRISPR’s RNA-based system offers greater adaptability, easier design, and exceptional accuracy. This accessibility and precision have allowed CRISPR’s application to expand across medicine, agriculture, manufacturing, and microbiology—such as engineering microorganisms to enhance production outputs. Nonetheless, as this article delves into, with increasing capabilities arise ethical dilemmas, particularly concerning germline editing and genetic enhancement.
First Patient of Customized CRISPR Therapy
In February 2025, the first personalized CRISPR therapy was administered to an infant named KJ to address a shortage of Carbamoyl Phosphate Synthetase 1 (CPS1)—an enzyme essential for converting ammonia (produced during protein degradation) into urea. A team spearheaded by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru at the Children’s Hospital of Philadelphia devised this treatment after extensive research in gene editing and cooperation with various clinicians.
Their efforts concentrated on ailments impacting the urea cycle, resulting in harmful ammonia accumulation, which can inflict damage on organs such as the brain and liver. They customized the treatment explicitly for KJ’s specific variation of CPS1 deficiency, utilizing preclinical studies on comparable variants.
Up to now, the only CRISPR therapies sanctioned by the U.S. FDA have been for more prevalent diseases such as sickle cell disease and beta thalassemia, affecting tens to hundreds of thousands of individuals. In KJ’s instance, his treatment was formulated within six months after birth, focusing on his particular CPS1 variant. The team developed a base editing therapy delivered through lipid nanoparticles to his liver to rectify the faulty enzyme.
The treatment administered in February was the first of three doses; KJ received the subsequent two in March and April 2025. By the time of his final dose, he has shown no significant adverse effects, demonstrates enhanced tolerance to dietary protein, and requires fewer medications to regulate ammonia levels. Although continuous monitoring will be necessary, Ahrens-Nicklas indicates that the outcomes so far are encouraging.
Ethical Implications of CRISPR
Like any innovative technology, CRISPR presents intricate ethical concerns